Combination therapy based on pegylated interferon alfa improves the therapeutic response of patients with chronic hepatitis B who exhibit high levels of hepatitis B e-antigen at 24 weeks A retrospective observational studyArticle Published on 2019-09-062023-06-03 Journal: Medicine [Category] B형 간염, [키워드] biological marker Chronic Hepatitis B combination therapy interferon nucleos(t)ide analogues response prediction [DOI] 10.1097/MD.0000000000017022 PMC 바로가기